Skip to main content
. 2022 Jul 27;10(4):e01507-22. doi: 10.1128/spectrum.01507-22

TABLE 1.

Patient information and HIV-1 subtypes analyzed in this study

Sample ID Age group Gender Nationality Estimated location of infection Estimated transmission routea CD4+ cell counts (cells/μL) Plasma viral load (copies/mL) HIV-1 subtype in coding region ofb
gag p17 pol PRRT pol IN env V3C4
TRN1 20s M Brazil Brazil MSM 219 11,500 B F B B
TRN2 20s F Brazil Unclear Hetero 303 47,800 B F F F
TRN3 30s M Philippines Japan MSM 368 57,600 01_AE 01_AE 01_AE B
TRN4 50s M Japan Japan or Thailand MSM 28 1,230,000 01_AE 01_AE 01_AE B
TRN5 30s M Brazil Brazil Hetero 396 54,700 C C B C
TRN6 30s F Brazil Brazil Hetero 229 8,130 C C B C
TRN7 30s M Brazil Japan MSM 285 32,400 C C B C
TRN8 30s M Japan Japan Hetero 761 21,000 B B B AE/B
TRN9 20s M Japan Japan or China MSM 229 40,400 C 01_AEc 01_AEc C
a

MSM, men who have sex with men; Hetero, heterosexual.

b

The subtype information was obtained from the data of the Sanger-based drug resistance test.

c

Excess numbers of mixed bases were detected in the drug resistance test.